ArticleCells2023

Early Pharmacodynamic Changes Measured Using RNA Sequencing of Peripheral Blood from Patients in a Phase I Study with Mitazalimab, a Potent CD40 Agonistic Monoclonal Antibody.

Hampus Andersson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.